SEC FORM 4
$257,138.16
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Sale of 2,300 shares at $111.7992 per share.
Reporting Person Mazabraud Yann · Officer Title EVP, Head of International · Transaction Code S
Traded Aug 12, 2026 · Disclosed Aug 14, 2026
Source: SEC Form 4 · 0001649904-26-000007 · filed 2026-08-14 · View filing →